Cynata Therapeutics Limited
CYYNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,050 | $10,508 | $6,205 | $11,167 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $105 | $0 | $113 | $77 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $195 | $357 | $218 | $217 |
| Total Curr. Assets | $5,349 | $10,864 | $6,536 | $11,460 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,849 | $0 | $1,852 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $1,995 | $0 | $1,992 |
| Total NC Assets | $1,849 | $1,995 | $1,852 | $1,992 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,198 | $12,860 | $8,388 | $13,452 |
| Liabilities | – | – | – | – |
| Payables | $394 | $1,139 | $432 | $682 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $822 | $233 | $739 | $500 |
| Total Curr. Liab. | $1,216 | $1,373 | $1,171 | $1,182 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,216 | $1,373 | $1,171 | $1,182 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $89,519 | $89,392 | $81,625 | $81,625 |
| Retained Earnings | -$91,709 | -$85,968 | -$82,319 | -$77,115 |
| AOCI | $8,172 | $8,063 | $7,911 | $7,761 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5,982 | $11,487 | $7,217 | $12,270 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,198 | $12,860 | $8,388 | $13,452 |
| Net Debt | -$5,050 | -$10,508 | -$6,205 | -$11,167 |